Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Journal of the National Cancer Institute
|
May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
Jonathan M Loree, Ann M Bailey, Amber M Johnson, et al.
BMC Cancer
|
July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach
Andrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.
Clinical and Translational Radiation Oncology
|
March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus
Emma B Holliday, Randa Tao, Zachary Brownlee, et al.
Nature Communications
|
June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Cancer
|
March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancer
Marc I Uemura, John T French, Kenneth R Hess, et al.
Clinical Colorectal Cancer
|
February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
Shailesh M Advani, Quilling Shi, Michael J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Annals of Surgical Oncology
|
September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival
Callisia N Clarke, Michael S Lee, Wei Wei, et al.
JCO Precision Oncology
|
July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT
Andrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal Cancer
Anastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Journal of the National Cancer Institute
|
May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
Jonathan M Loree, Ann M Bailey, Amber M Johnson, et al.
BMC Cancer
|
July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach
Andrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.
Clinical and Translational Radiation Oncology
|
March 30, 2018
Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus
Emma B Holliday, Randa Tao, Zachary Brownlee, et al.
Nature Communications
|
June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Cancer
|
March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancer
Marc I Uemura, John T French, Kenneth R Hess, et al.
Clinical Colorectal Cancer
|
February 4, 2020
Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
Shailesh M Advani, Quilling Shi, Michael J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2021
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, et al.
Annals of Surgical Oncology
|
September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival
Callisia N Clarke, Michael S Lee, Wei Wei, et al.
JCO Precision Oncology
|
July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT
Andrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal Cancer
Anastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Page
of 11